CROHN’S DISEASE STUDY
Altasciences is looking for participants aged 18 to 75 with Crohn's disease.
If eligible, you could receive up to $5,325 for your participation.
Multiple groups are available.
Verify your eligibility by filling out the form below or by calling us at (514) 381-2546 for more information.
STUDY
| Study G35 |
| Age: 18 - 75 |
| Gender: Men - Women |
| Category: Non-smoker |
| BMI: 18.50 - 35.00 |
| Compensation: $5,325 |
| Clinic stay: multiple dates available. |
| Medication type: this drug is indicated in the treatment of ulcerative colitis, a chronic condition that causes inflammation and sores (ulcers) in the lining of the large intestine (colon) and rectum. |
| Notes
- We are looking for participants with Crohn's disease. - Phase 1 study. - Participants must be fasted prior to dosing. - Participants will remain seated for at least four hours after taking the medication. - Blood volume: less than 500ml. - Overnight blood draws. - Other groups are available with different dates. If you are available for different groups, let us know when you sign up. More details will be given to you over the phone. - Your medical history and/or medication intake history may affect your participation on this study. - Please note that we are testing for drugs and alcohol during the medical evaluation. |
